---
title: "Creative Medical Tech surges 106% in regular trading on Type 1 diabetes patent approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295128150.md"
description: "CELZ shares surged 106% after the USPTO approved a patent for its exosome-based Type 1 diabetes immunotherapy."
datetime: "2026-08-06T16:29:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295128150.md)
  - [en](https://longbridge.com/en/news/295128150.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295128150.md)
---

# Creative Medical Tech surges 106% in regular trading on Type 1 diabetes patent approval

Creative Medical Tech(CELZ.US) 盘中涨超 106%，现报 1.38 美元。

消息面上，公司近期获美国专利商标局批准一项关于外泌体基 1 型糖尿病免疫疗法的专利申请。该疗法旨在通过干细胞编程的髓系细胞外泌体诱导免疫耐受并保护胰腺β细胞，扩展了 MyeloCelz 平台的保护范围。此前公司已获得多项专利，保护期延伸至 2042-2043 年，涵盖 CELZ-201 和 CELZ-101 等产品线。

此外，医疗健康板块整体波动较大，多只生物科技小盘股出现显著波动，板块情绪活跃。

### Related Stocks

- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)

## Related News & Research

- [Creative Medical gets USPTO notice of allowance for exosome-based Type 1 diabetes immunotherapy patent application](https://longbridge.com/en/news/295116081.md)
- [Creative Medical Technology Holdings issues mid-year update press release](https://longbridge.com/en/news/291420127.md)
- [Top 3 Real Estate Stocks That May Keep You Up At Night In August](https://longbridge.com/en/news/296231864.md)
- [Instagram Head of Product Design Explains Thinking Behind That New Logo and Responds to Critics: ‘It’s Important for Us to Embrace the Future’](https://longbridge.com/en/news/296134477.md)
- [LG Display Co., Ltd. $LPL Shares Sold by Renaissance Technologies LLC](https://longbridge.com/en/news/296076871.md)